Early-Onset Type 2 Diabetes Mellitus Among Adolescents and Young Adults: Clinical Profiles and Risk Factors

Abstract

Background. Type 2 diabetes mellitus (T2DM), historically a disease of middle and older age, is increasingly diagnosed in adolescents and young adults. This shift carries disproportionate clinical consequences: youth-onset T2DM follows a more aggressive course than adult-onset disease, with rapid loss of beta-cell function and early onset of complications.

Objective. This review synthesises current evidence on the epidemiology, pathophysiology, clinical profile, risk factors, and complication burden of early-onset T2DM in adolescents and young adults, and considers the implications for screening and management.

Methods. We undertook a structured narrative review of peer-reviewed literature, landmark cohort and intervention studies (notably SEARCH for Diabetes in Youth, TODAY, and RISE), and contemporary international reviews and guidelines.

Results. In the US SEARCH study, the prevalence of youth T2DM rose from 0.34 per 1,000 in 2001 to 0.67 per 1,000 in 2017—a relative increase of roughly 95% over 16 years—with the burden concentrated in Black, American Indian, Hispanic, and Asian/Pacific Islander youth. The TODAY study found that approximately half of participants failed metformin-based therapy within a few years, driven by beta-cell decline of roughly 20–35% per year; any microvascular complication reached a cumulative incidence of 80% by 15 years of disease duration. Obesity, family history, ethnicity, intrauterine exposure to maternal diabetes, and markers of insulin resistance are principal risk factors.

Conclusion. Early-onset T2DM is a rising global problem with a distinctly aggressive phenotype and an early, heavy complication burden. Earlier and more intensive intervention, targeted screening of high-risk youth, and attention to the psychosocial and reproductive dimensions of care are urgently needed.